HB 1260: Relating to the disclosure of financial interests by and the regulation of advertising by health care practitioners who promote or facilitate the sale of drugs to consumers; providing administrative and civil penalties.
- Session
- 90th Texas Legislature, Regular Session
- Status
- Filed
- Filed
- Nov 20, 2026
- Most recent action
- 11/20/2026 H Filed
- Authors
- McGee
- Official subjects
- Business & Commerce--General; Civil Remedies & Liabilities; Health Care Providers; ADVERTISING; MEDICINE & PRESCRIPTION DRUGS; PHARMACIES & PHARMACISTS; TELEMEDICINE; HEALTH PROFESSIONS COUNCIL
AI summary (not official): Requires drug-selling practitioners to disclose financial interests, support health claims, and follow prescribing rules.
Topics: Healthcare, Local government, Business regulation. From AI review or caption rules.
Agencies it could affect (possible, not confirmed): Office of the Attorney General, Health Professions Council, Texas State Board of Pharmacy. From AI review or caption rules.
Laws this bill changes
- amends Health and Safety Code chapter 446
- adds Health and Safety Code § 446.003
- adds Health and Safety Code § 446.004
- adds Occupations Code chapter 118
- adds Occupations Code § 118.001
- adds Occupations Code § 118.002
- adds Occupations Code § 118.003
- adds Occupations Code § 118.004
- adds Occupations Code § 118.005
- adds Occupations Code § 118.006
- adds Occupations Code § 118.007
- adds Occupations Code § 118.008
- adds Occupations Code § 118.009
- amends Occupations Code § 154.006
Bill text (Introduced)
By: McGee H.B. No. 1260
A BILL TO BE ENTITLED
AN ACT
relating to the disclosure of financial interests by and the regulation of advertising by health care practitioners who promote or facilitate the sale of drugs to consumers; providing administrative and civil penalties.
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
SECTION 1.
SHORT TITLE. This Act may be cited as the Practitioner Drug Promotion Transparency Act.
SECTION 2.
Subtitle A, Title 3, Occupations Code, is amended by adding Chapter 118 to read as follows: CHAPTER 118. PROMOTION AND SALE OF DRUGS BY HEALTH CARE PRACTITIONERS
Sec. 118.001. DEFINITIONS. In this chapter:
(1) "Advertising" means any communication made to the public or to a consumer, in any medium, that promotes the purchase or use of a drug, including a statement made on an Internet website, a social media platform, a newsletter, a subscription publication, a podcast, a broadcast, a video, a livestream, an e-mail, or a text message, and including a link, discount code, or other means of directing a consumer to a point of sale.
(2) "Affiliated entity" means a person in which a health care practitioner or a member of the practitioner's immediate family holds a financial interest, including a pharmacy, telemedicine platform, distributor, wholesaler, or online retailer.
(3) "Covered sale" means a sale or dispensing of a drug to a consumer in this state in which a health care practitioner has a financial interest, whether the drug is dispensed under a prescription drug order, under a statewide standing order or protocol, or without a prescription.
(4) "Drug" has the meaning assigned by Section 431.002, Health and Safety Code, and includes a compounded drug.
(5) "Financial interest" means any direct or indirect interest in, or expectation of, remuneration that varies with or is contingent on the sale of a drug, including:
(A) an ownership or investment interest in an affiliated entity;
(B) a commission, affiliate fee, referral fee, royalty, or share of revenue or profit;
(C) compensation attributable to a discount code, tracking link, or similar referral mechanism; and
(D) a consulting, speaking, sponsorship, or licensing fee paid by a person that manufactures, compounds, distributes, or dispenses the drug. The term does not include ownership of less than one percent of the outstanding securities of a publicly traded company, or a reasonable fee for professional services lawfully billed to a patient that does not vary with the patient's purchase of a particular drug.
(6) "Health care practitioner" means an individual licensed, certified, or registered under this title who is authorized to prescribe or order a drug.
(7) "Licensing authority" means the state agency that issued the health care practitioner's license, certification, or registration.
(8) "Unapproved use" means the use of a drug for a disease, condition, or purpose that is not included in the drug's labeling approved by the United States Food and Drug Administration.
Sec. 118.002. APPLICABILITY. This chapter applies to a health care practitioner who, directly or through an affiliated entity or agent, advertises a drug in which the practitioner has a financial interest or facilitates a covered sale, regardless of whether the practitioner has a practitioner-patient relationship with the consumer.
The text continues: full text of HB 1260.
Links
- Full bill text (Introduced), Markdown copy of the official file
- Record, history and review for AI agents
- Official bill history on Texas Legislature Online
Texas Bill Atlas is an independent research tool, not an official state website.